Table 2.
Metabolic parameters by weight status and metabolic subtype
Characteristics | Normal Weight (BMI 18.5–24.9 kg/m2) | Overweight (BMI 25–29.9 kg/m2) | Obese (BMI ≥30 kg/m2) | |||
---|---|---|---|---|---|---|
Metabolically Healthy (n=777) | Metabolically Unhealthy (n=178) | Metabolically Healthy (n=771) | Metabolically Unhealthy (n=752) | Metabolically Healthy (n=425) | Metabolically Unhealthy (n=1471) | |
Waist circumference (cm) | 82.5±9.3 | 89.4±10.1a | 91.9±9.4 | 97.9±9.1a | 103.7±13.6 | 112.3±12.8a |
Elevated waist circumferenceb | 4.3 | 27.5 | 21.0 | 65 | 72.2 | 96.1 |
Fasting triglycerides (mg/dl) | 103.0±45.9 | 198.6±88.9a | 108.6±49.7 | 188.5±145.3a | 99.6±34.5 | 168.9±107.3a |
Triglycerides ≥150 mg/dl | 10.6 | 70.8 | 11.3 | 58.8 | 4.0 | 46.9 |
HDL (mg/dl) | 58.5±16.9 | 42.4±13.1a | 55.4±16.0 | 43.1±13.0a | 56.9±14.7 | 44.7±13.8a |
Low HDLc | 16.6 | 74.2 | 17.9 | 66.2 | 11.1 | 61.3 |
Fasting glucose (mg/dl) | 93.6±24.0 | 121.5±58.1a | 98.6±31.8 | 118.2±47.9 | 97.0±33.9 | 126.4±52.9a |
Elevated fasting glucosed | 21.2 | 72.5 | 23.7 | 71.9 | 16.5 | 82.0 |
SBP (mmHg) | 128.5±19.0 | 133.8±17.3a | 130.0±18.1 | 134.7±17.8a | 130.9±16.3 | 135.7±18.2a |
DBP (mmHg) | 74.6±10.5 | 75.7±9.3 | 76.5±10.0 | 76.8±10.3 | 79.1±10.2 | 78.9±11.0 |
Elevated BPe | 70.4 | 94.9 | 72.4 | 94.1 | 73.4 | 95.0 |
hsCRP (mg/L) | 1.6 (0.7–4.5) | 2.7 (1.3–6.9)a | 2.1 (0.9–4.5) | 2.5 (1.2–5.7)f | 3.2 (1.5–6.5) | 4.2 (2.0–8.3)a |
LDL (mg/dl) | 108.3±33.9 | 107.2±37.0 | 112.5±35.3 | 112.1±37.2 | 114.9±33.6 | 109.6±35.7f |
Data are presented as the mean ± SD, median (interquartile range), or frequency. SBP, systolic BP; DBP, diastolic BP; hsCRP, high-sensitivity C-reactive protein.
P<0.001 for difference between metabolic subtypes within individual weight categories.
Defined as waist circumference >102 for men or >88 cm for women.
Defined as <40 mg/dl for men or <50 mg/dl for women.
Defined as fasting glucose ≥100 mg/dl, history of diabetes, or current antidiabetic medication use.
Defined as SBP ≥130 mmHg, DBP ≥85 mmHg, and/or current antihypertensive medication use.
P<0.05 for difference between metabolic subtypes within individual weight categories.